株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

治療用酵素の世界市場:2025年までの予測

Global Therapeutic Enzymes Market Insights, Forecast to 2025

発行 QYResearch 商品コード 891742
出版日 ページ情報 英文 163 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.21円で換算しております。
Back to Top
治療用酵素の世界市場:2025年までの予測 Global Therapeutic Enzymes Market Insights, Forecast to 2025
出版日: 2019年09月09日 ページ情報: 英文 163 Pages
概要

世界の治療用酵素市場は、2018年の79億3573万米ドルから、2025年には170億4509万米ドルまで拡大すると見られています。市場は、2019年~2025年のCAGR (複合年間成長率) で、12.06%の成長が予測されています。

当レポートでは、世界の治療用酵素市場について調査分析し、市場規模、市場状況、競合情勢、市場シェア、成長率、将来動向、市場促進要因、機会・課題、販売チャネル・流通業者について、体系的な情報を提供しています。

第1章 調査範囲

第2章 エグゼクティブサマリー

第3章 内訳データ:メーカー別

  • 売上:メーカー別
  • 収益:メーカー別
  • 価格:メーカー別
  • 本社、設立日、製品タイプ
  • M&A、事業拡大計画

第4章 内訳データ:タイプ別

  • 売上:タイプ別
  • 収益:タイプ別
  • 価格:タイプ別

第5章 内訳データ:用途別

  • 概要
  • 内訳データ:用途別

第6章 北米

  • 国別
  • タイプ別
  • 用途別

第7章 欧州

  • 国別
  • タイプ別
  • 用途別

第8章 アジア太平洋地域

  • 国別
  • タイプ別
  • 用途別

第9章 南米

  • 国別
  • タイプ別
  • 用途別

第10章 中東・アフリカ

  • 国別
  • タイプ別
  • 用途別

第11章 主要メーカーの分析

  • Sanofi
  • BioMarin
  • AbbVie
  • Shire
  • Alexion
  • Horizon Pharma
  • Allergan
  • Johnson & Johnson
  • Recordati Rare Diseases
  • Pfizer
  • Vivus
  • Digestive Care
  • Leadiant Biosciences

第12章 将来予測

  • 市場予測:地域別
  • 市場予測:タイプ別
  • 市場予測:用途別
  • 北米
  • 欧州
  • アジア太平洋地域
  • 南米
  • 中東・アフリカ

第13章 市場機会・課題・リスク・影響要因分析

  • 市場機会・促進要因
  • 市場課題
  • 新薬開発
  • ファイブフォース分析

第14章 バリューチェーン・販売チャネル分析

  • バリューチェーン分析
  • 顧客
  • 販売チャネル分析

第15章 主な調査結果・結論

第16章 付録

図表
  • Figure Therapeutic Enzymes Product Picture 1
  • Table Therapeutic Enzymes Market Segments 2
  • Table Key Manufacturers of Therapeutic Enzymes Covered 3
  • Table Global Therapeutic Enzymes Market Size Growth Rate by Type (2019-2025) (K Unit) & (Million US$) 3
  • Figure Global Therapeutic Enzymes Revenue Market Share by Type in 2018 4
  • Figure Global Therapeutic Enzymes Revenue Market Share by Type in 2025 5
  • Figure Injectable Product Picture 5
  • Figure Oral Product Picture 6
  • Figure Topical Product Picture 6
  • Table Global Therapeutic Enzymes Market Size Growth Rate by Application (2019-2025) (M USD) 7
  • Figure Global Therapeutic Enzymes Revenue Market Share by Application in 2018 7
  • Figure Global Therapeutic Enzymes Revenue Market Share by Application in 2025 8
  • Figure Gaucher Disease 9
  • Figure MPS Disease 10
  • Figure Gastrointestinal Diseases 10
  • Figure Therapeutic Enzymes Report Years Considered 12
  • Figure Global Therapeutic Enzymes Market Size 2014-2025 (Million US$) 14
  • Figure Global Therapeutic Enzymes Sales 2014-2025 (K Unit) 15
  • Table Global Therapeutic Enzymes Market Size by Region (2019-2025) (K Unit) & (Million US$) 15
  • Figure Global Therapeutic Enzymes Market Size Market Share by Region (2019-2025) 16
  • Table Global Therapeutic Enzymes Sales by Region (2014-2019) (K Unit) 16
  • Table Global Therapeutic Enzymes Sales Market Share by Region (2014-2019) 16
  • Figure Global Therapeutic Enzymes Sales Market Share by Region (2014-2019) 17
  • Figure Global Therapeutic Enzymes Sales Market Share by Region in 2018 17
  • Table Global Market Size (M USD) of Difference Types of Therapeutic Enzymes by Region 18
  • Table Global Therapeutic Enzymes Revenue by Region (2014-2019) (Million US$) 18
  • Figure Global Therapeutic Enzymes Revenue Market Share by Region (2014-2019) 19
  • Figure Global Therapeutic Enzymes Revenue Market Share by Region in 2018 19
  • Table Global Therapeutic Enzymes Sales by Manufacturer (2018-2019) (K Unit) 20
  • Table Global Therapeutic Enzymes Sales Share by Manufacturer (2018-2019) 21
  • Figure Global Therapeutic Enzymes Sales Share by Manufacturer in 2018 22
  • Table Therapeutic Enzymes Revenue by Manufacturer (2018-2019) (Million USD) 23
  • Table Therapeutic Enzymes Revenue Share by Manufacturer (2018-2019) 23
  • Figure Therapeutic Enzymes Revenue Share by Manufacturer in 2018 24
  • Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) 24
  • Table Key Manufacturers Therapeutic Enzymes Price (2018-2019) (USD/Unit) 25
  • Table Therapeutic Enzymes Manufacturers Headquarters and Established Date 25
  • Table Manufacturers Therapeutic Enzymes Product Type 26
  • Table Manufacturers Mergers & Acquisitions, Expansion Plans 27
  • Table Global Therapeutic Enzymes Sales by Type (2014-2019) (K Unit) 33
  • Table Global Therapeutic Enzymes Sales Share by Type (2014-2019) 33
  • Figure Global Therapeutic Enzymes Sales Market Share by Type (2014-2019) 33
  • Figure Global Therapeutic Enzymes Sales Market Share by Type in 2018 34
  • Table Global Therapeutic Enzymes Revenue by Type (2014-2019) (Million US$) 34
  • Table Global Therapeutic Enzymes Revenue Share by Type (2014-2019) 34
  • Figure Global Therapeutic Enzymes Revenue Market Share by Type (2014-2019) 35
  • Figure Global Therapeutic Enzymes Revenue Market Share by Type in 2018 35
  • Table Therapeutic Enzymes Price by Type (2014-2019) (USD/Unit) 36
  • Figure Global Market Size of Therapeutic Enzymes by Applications (M USD) 37
  • Table Global Therapeutic Enzymes Market Size by Application (2014-2019) (M USD) 37
  • Table Global Therapeutic Enzymes Market Size Share by Application (2014-2019) 38
  • Figure Global Therapeutic Enzymes Market Share by Application (2014-2019) 38
  • Figure Global Therapeutic Enzymes Market Share by Application in 2018 39
  • Figure North America Therapeutic Enzymes Sales Growth Rate 2014-2019 (K Unit) 40
  • Figure North America Therapeutic Enzymes Revenue Growth Rate 2014-2019 (Million US$) 41
  • Table North America Therapeutic Enzymes Sales by Country (2014-2019) (K Unit) 41
  • Table North America Therapeutic Enzymes Sales Market Share by Country (2014-2019) 41
  • Figure North America Therapeutic Enzymes Sales Market Share by Country in 2018 42
  • Table North America Therapeutic Enzymes Revenue by Country (2014-2019) (Million US$) 42
  • Table North America Therapeutic Enzymes Revenue Market Share by Country (2014-2019) 42
  • Figure North America Therapeutic Enzymes Revenue Market Share by Country in 2018 43
  • Figure United States Therapeutic Enzymes Sales Growth Rate (2014-2019) (K Unit) 44
  • Figure United States Therapeutic Enzymes Revenue Growth Rate (2014-2019) (Million US$) 44
  • Figure Canada Therapeutic Enzymes Sales Growth Rate (2014-2019) (K Unit) 45
  • Figure Canada Therapeutic Enzymes Revenue Growth Rate (2014-2019) (Million US$) 45
  • Figure Mexico Therapeutic Enzymes Sales Growth Rate (2014-2019) (K Unit) 46
  • Figure Mexico Therapeutic Enzymes Revenue Growth Rate (2014-2019) (Million US$) 46
  • Table North America Therapeutic Enzymes Market Size by Type (2014-2019) (M USD) 47
  • Table North America Therapeutic Enzymes Sales Market Share by Type (2014-2019) 47
  • Figure North America Therapeutic Enzymes Market Share by Type in 2018 47
  • Table North America Therapeutic Enzymes Market Size by Application (2014-2019) (M USD) 48
  • Table North America Therapeutic Enzymes Market Size Market Share by Application (2014-2019) 48
  • Figure North America Therapeutic Enzymes Market Share by Application in 2018 49
  • Figure Europe Therapeutic Enzymes Sales Growth Rate 2014-2019 (K Unit) 50
  • Figure Europe Therapeutic Enzymes Revenue Growth Rate 2014-2019 (Million US$) 50
  • Table Europe Therapeutic Enzymes Sales by Country (2014-2019) (K Unit) 51
  • Table Europe Therapeutic Enzymes Sales Market Share by Country (2014-2019) 51
  • Figure Europe Therapeutic Enzymes Sales Market Share by Country in 2018 52
  • Table Europe Therapeutic Enzymes Revenue by Country (2014-2019) (Million US$) 52
  • Table Europe Therapeutic Enzymes Revenue Market Share by Country (2014-2019) 52
  • Figure Europe Therapeutic Enzymes Revenue Market Share by Country in 2018 53
  • Figure Germany Therapeutic Enzymes Sales Growth Rate (2014-2019) (K Unit) 54
  • Figure Germany Therapeutic Enzymes Revenue Growth Rate (2014-2019) (Million US$) 54
  • Figure France Therapeutic Enzymes Sales Growth Rate (2014-2019) (K Unit) 55
  • Figure France Therapeutic Enzymes Revenue Growth Rate (2014-2019) (Million US$) 55
  • Figure UK Therapeutic Enzymes Sales Growth Rate (2014-2019) (K Unit) 56
  • Figure UK Therapeutic Enzymes Revenue Growth Rate (2014-2019) (Million US$) 56
  • Figure Italy Therapeutic Enzymes Sales Growth Rate (2014-2019) (K Unit) 57
  • Figure Italy Therapeutic Enzymes Revenue Growth Rate (2014-2019) (Million US$) 57
  • Figure Russia Therapeutic Enzymes Sales Growth Rate (2014-2019) (K Unit) 58
  • Figure Russia Therapeutic Enzymes Revenue Growth Rate (2014-2019) (Million US$) 58
  • Table Europe Therapeutic Enzymes Market Size by Type (2014-2019) (M USD) 59
  • Table Europe Therapeutic Enzymes Market Size Market Share by Type (2014-2019) 59
  • Figure Europe Therapeutic Enzymes Market Share by Type in 2018 59
  • Table Europe Therapeutic Enzymes Market Size by Application (2014-2019) (M USD) 60
  • Table Europe Therapeutic Enzymes Market Size Market Share by Application (2014-2019) 60
  • Figure Europe Therapeutic Enzymes Market Share by Application in 2018 60
  • Figure Asia Pacific Therapeutic Enzymes Sales Growth Rate 2014-2019 (K Unit) 61
  • Figure Asia Pacific Therapeutic Enzymes Revenue Growth Rate 2014-2019 (Million US$) 61
  • Table Asia Pacific Therapeutic Enzymes Sales by Region (2014-2019) (K Unit) 62
  • Table Asia Pacific Therapeutic Enzymes Sales Market Share by Region (2014-2019) 62
  • Figure Asia Pacific Therapeutic Enzymes Sales Market Share by Region in 2018 63
  • Table Asia Pacific Therapeutic Enzymes Revenue by Region (2014-2019) (Million US$) 63
  • Table Asia Pacific Therapeutic Enzymes Revenue Market Share by Region (2014-2019) 63
  • Figure Asia Pacific Therapeutic Enzymes Revenue Market Share by Region in 2018 64
  • Figure China Therapeutic Enzymes Sales Growth Rate (2014-2019) (K Unit) 65
  • Figure China Therapeutic Enzymes Revenue Growth Rate (2014-2019) (Million US$) 65
  • Figure Japan Therapeutic Enzymes Sales Growth Rate (2014-2019) (K Unit) 66
  • Figure Japan Therapeutic Enzymes Revenue Growth Rate (2014-2019) (Million US$) 66
  • Figure South Korea Therapeutic Enzymes Sales Growth Rate (2014-2019) (K Unit) 67
  • Figure South Korea Therapeutic Enzymes Revenue Growth Rate (2014-2019) (Million US$) 67
  • Figure India Therapeutic Enzymes Sales Growth Rate (2014-2019) (K Unit) 68
  • Figure India Therapeutic Enzymes Revenue Growth Rate (2014-2019) (Million US$) 68
  • Figure Southeast Asia Therapeutic Enzymes Sales Growth Rate (2014-2019) (K Unit) 69
  • Figure Australia Therapeutic Enzymes Revenue Growth Rate (2014-2019) (Million US$) 69
  • Table Asia Pacific Therapeutic Enzymes Market Size by Type (2014-2019) (M USD) 70
  • Table Asia Pacific Therapeutic Enzymes Market Size Market Share by Type (2014-2019) 70
  • Figure Asia Pacific Therapeutic Enzymes Market Share by Type in 2018 70
  • Table Asia Pacific Therapeutic Enzymes Market Size by Application (2014-2019) (M USD) 71
  • Table Asia Pacific Therapeutic Enzymes Market Size Market Share by Application (2014-2019) 71
  • Figure Asia Pacific Therapeutic Enzymes Market Share by Application in 2018 71
  • Figure South America Therapeutic Enzymes Sales Growth Rate 2014-2019 (K Unit) 72
  • Figure South America Therapeutic Enzymes Revenue Growth Rate 2014-2019 (Million US$) 73
  • Table South America Therapeutic Enzymes Sales by Country (2014-2019) (K Unit) 73
  • Table South America Therapeutic Enzymes Sales Market Share by Country (2014-2019) 73
  • Figure South America Therapeutic Enzymes Sales Market Share by Country in 2018 74
  • Table South America Therapeutic Enzymes Revenue by Country (2014-2019) (Million US$) 74
  • Table South America Therapeutic Enzymes Revenue Market Share by Country (2014-2019) 75
  • Figure South America Therapeutic Enzymes Revenue Market Share by Country in 2018 75
  • Figure Brazil Therapeutic Enzymes Sales Growth Rate (2014-2019) (K Unit) 76
  • Figure Brazil Therapeutic Enzymes Revenue Growth Rate (2014-2019) (Million US$) 76
  • Table South America Therapeutic Enzymes Revenue by Type (2014-2019) (M USD) 77
  • Table South America Therapeutic Enzymes Revenue Market Share by Type (2014-2019) 77
  • Figure South America Therapeutic Enzymes Market Share by Type in 2018 77
  • Table South America Therapeutic Enzymes Revenue by Application (2014-2019) (M USD) 78
  • Table South America Therapeutic Enzymes Sales Market Share by Application (2014-2019) 78
  • Figure South America Therapeutic Enzymes Market Share by Application in 2018 79
  • Figure Middle East and Africa Therapeutic Enzymes Sales Growth Rate 2014-2019 (K Unit) 80
  • Figure Middle East and Africa Therapeutic Enzymes Revenue Growth Rate 2014-2019 (Million US$) 80
  • Table Middle East and Africa Therapeutic Enzymes Sales by Country (2014-2019) (K Unit) 81
  • Table Middle East and Africa Therapeutic Enzymes Sales Market Share by Country (2014-2019) 81
  • Figure Middle East and Africa Therapeutic Enzymes Sales Market Share by Country in 2018 82
  • Table Middle East and Africa Therapeutic Enzymes Revenue by Country (2014-2019) (Million US$) 82
  • Table Middle East and Africa Therapeutic Enzymes Revenue Market Share by Country (2014-2019) 82
  • Figure Middle East and Africa Therapeutic Enzymes Revenue Market Share by Country in 2018 83
  • Figure Egypt Therapeutic Enzymes Sales Growth Rate (2014-2019) (K Unit) 83
  • Figure Egypt Therapeutic Enzymes Revenue Growth Rate (2014-2019) (Million US$) 84
  • Figure South Africa Therapeutic Enzymes Sales Growth Rate (2014-2019) (K Unit) 85
  • Figure South Africa Therapeutic Enzymes Revenue Growth Rate (2014-2019) (Million US$) 86
  • Table Middle East and Africa Therapeutic Enzymes Revenue by Type (2014-2019) (M USD) 86
  • Table Middle East and Africa Therapeutic Enzymes Revenue Market Share by Type (2014-2019) 86
  • Figure Middle East and Africa Therapeutic Enzymes Market Share by Type in 2018 87
  • Table Middle East and Africa Therapeutic Enzymes Revenue by Application (2014-2019) (M USD) 87
  • Table Middle East and Africa Therapeutic Enzymes Revenue Market Share by Application (2014-2019) 88
  • Figure Middle East and Africa Therapeutic Enzymes Market Share by Application in 2018 88
  • Table Sanofi Company Profile 89
  • Table Therapeutic Enzymes Product Introduction of Sanofi 90
  • Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2018-2019 91
  • Table BioMarin Company Profile 91
  • Table Therapeutic Enzymes Product Introduction of BioMarin 93
  • Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of BioMarin 2018-2019 93
  • Table AbbVie Company Profile 94
  • Table Therapeutic Enzymes Product Introduction of AbbVie 96
  • Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AbbVie 2018-2019 96
  • Table Shire Company Profile 97
  • Table Therapeutic Enzymes Product Introduction of Shire 98
  • Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Shire 2018-2019 99
  • Table Alexion Company Profile 99
  • Table Therapeutic Enzymes Product Introduction of Alexion 100
  • Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Alexion 2018-2019 101
  • Table Horizon Pharma Company Profile 101
  • Table Therapeutic Enzymes Product Introduction of Horizon Pharma 102
  • Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Horizon Pharma 2018-2019 103
  • Table Allergan Company Profile 103
  • Table Therapeutic Enzymes Product Introduction of Allergan 104
  • Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Allergan 2018-2019 105
  • Table Johnson & Johnson Company Profile 105
  • Table Therapeutic Enzymes Product Introduction of Johnson & Johnson 106
  • Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2018-2019 107
  • Table Recordati Rare Diseases Company Profile 107
  • Table Therapeutic Enzymes Product Introduction of Recordati Rare Diseases 108
  • Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Recordati Rare Diseases 2018-2019 109
  • Table Pfizer Company Profile 109
  • Table Therapeutic Enzymes Product Introduction of Pfizer 110
  • Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2018-2019 111
  • Table Vivus Company Profile 111
  • Table Therapeutic Enzymes Product Introduction of Vivus 112
  • Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Vivus 2018-2019 113
  • Table Digestive Care Company Profile 113
  • Table Therapeutic Enzymes Product Introduction of Digestive Care 114
  • Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Digestive Care 2018-2019 115
  • Table Leadiant Biosciences Company Profile 115
  • Table Therapeutic Enzymes Product Introduction of Leadiant Biosciences 116
  • Table Therapeutic Enzymes Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Leadiant Biosciences 2018-2019 117
  • Table Global Therapeutic Enzymes Sales Forecast by Region (2020-2025) (K Unit) 118
  • Table Global Therapeutic Enzymes Sales Market Share Forecast by Region (2020-2025) 118
  • Table Global Therapeutic Enzymes Revenue Forecast by Region (2020-2025) (Million US$) 119
  • Table Global Therapeutic Enzymes Revenue Market Share Forecast by Region (2020-2025) 119
  • Table Forecast Revenue (M USD) of Difference Types of Therapeutic Enzymes by Region (2020-2025) 119
  • Table Global Therapeutic Enzymes Sales Forecast by Type (2020-2025) (K Unit) 120
  • Table Global Therapeutic Enzymes Sales Market Share Forecast by Type (2020-2025) 120
  • Table Global Therapeutic Enzymes Revenue Forecast by Type (2020-2025) (Million US$) 121
  • Table Global Therapeutic Enzymes Revenue Market Share Forecast by Type (2020-2025) 121
  • Table Global Therapeutic Enzymes Revenue Forecast by Application (2020-2025) (M USD) 121
  • Table Global Therapeutic Enzymes Revenue Market Share Forecast by Application (2020-2025) 121
  • Figure North America Therapeutic Enzymes Sales Growth Rate Forecast (2020-2025) (K Unit) 122
  • Figure North America Therapeutic Enzymes Revenue Growth Rate Forecast (2020-2025) (Million US$) 123
  • Figure Europe Therapeutic Enzymes Sales Growth Rate Forecast (2020-2025) (K Unit) 123
  • Figure Europe Therapeutic Enzymes Revenue Growth Rate Forecast (2020-2025) (Million US$) 124
  • Figure Asia Pacific Therapeutic Enzymes Sales Growth Rate Forecast (2020-2025) (K Unit) 124
  • Figure Asia Pacific Therapeutic Enzymes Revenue Growth Rate Forecast (2020-2025) (Million US$) 125
  • Figure South America Therapeutic Enzymes Sales Growth Rate Forecast (2020-2025) (K Unit) 125
  • Figure South America Therapeutic Enzymes Revenue Growth Rate Forecast (2020-2025) (Million US$) 126
  • Figure Middle East and Africa Therapeutic Enzymes Sales Growth Rate Forecast (2020-2025) (K Unit) 126
  • Figure Middle East and Africa Therapeutic Enzymes Revenue Growth Rate Forecast (2020-2025) (Million US$) 127
  • Table Key Opportunities and Drivers: Impact Analysis (2019-2025) 129
  • Table Key Challenges 129
  • Figure RVT-801 (RHAC) Pipeline 132
  • Figure Porter's Five Forces Analysis 133
  • Figure Therapeutic Enzymes Value Chain 134
  • Table Therapeutic Enzymes Customers List 135
  • Figure Channels of Distribution 138
  • Table Therapeutic Enzymes Distributors List 138
  • Figure Distributors Profiles 140
  • Table Research Programs/Design for This Report 142
  • Figure Bottom-up and Top-down Approaches for This Report 144
  • Figure Data Triangulation 145
  • Figure Key Executives Interviewed 146
  • Table Key Data Information from Secondary Sources 147
  • Table Key Data Information from Primary Sources 147
目次

This report presents the worldwide Therapeutic Enzymes market size (value, production and consumption), splits the breakdown (history data 2014-2019 and forecast to 2025), by manufacturer, region, type and application.

This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

In 2018, the global Therapeutic Enzymes market size was increased to 7935.73 million US$ from 5081.36 million US$ in 2014, and it will reach 17045.09 million US$ in 2025, growing at CAGR of 12.06% between 2019 and 2025.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Sanofi

BioMarin

AbbVie

Shire

Alexion

Horizon Pharma

Allergan

Johnson & Johnson

Recordati Rare Diseases

Pfizer

Vivus

Digestive Care

Leadiant Biosciences

Therapeutic Enzymes market size by type:

Injectable

Oral

Topical

Therapeutic Enzymes market size by Applications:

Gaucher Disease

MPS Disease

Gastrointestinal Diseases

Others

Therapeutic Enzymes market size by region

North America

United States

Canada

Mexico

Asia-Pacific

China

Japan

Korea

India

Southeast Asia

Europe

Germany

France

UK

Italy

Russia

South America

Brazil

Middle East & Africa

Egypt

South Africa

1 Study Coverage 1

  • 1.1 Therapeutic Enzymes Product Introduction 1
  • 1.2 Market Segments 1
  • 1.3 Key Manufacturers Covered 2
  • 1.4 Market by Type 3
    • 1.4.1 Global Therapeutic Enzymes Market Size Growth Rate by Type 3
    • 1.4.2 Injectable 5
    • 1.4.3 Oral 6
    • 1.4.4 Topical 6
  • 1.5 Market by Application 6
    • 1.5.1 Global Therapeutic Enzymes Market Size Growth Rate by Application 7
    • 1.5.2 Gaucher Disease 8
    • 1.5.3 MPS Disease 9
    • 1.5.4 Gastrointestinal Diseases 10
  • 1.6 Study Objectives 11
  • 1.7 Years Considered 12

2 Executive Summary 13

  • 2.1 Global Therapeutic Enzymes Market Size 13
    • 2.1.1 Global Therapeutic Enzymes Revenue 2014-2025 13
    • 2.1.2 Global Therapeutic Enzymes Sales 2014-2025 14
  • 2.2 Therapeutic Enzymes Growth Rate by Region 15
    • 2.2.1 Global Therapeutic Enzymes Sales by Region 16
    • 2.2.2 Global Market Size of Difference Types of Therapeutic Enzymes by Region 18
    • 2.2.3 Global Therapeutic Enzymes Revenue by Region 18

3 Breakdown Data by Manufacturer 20

  • 3.1 Therapeutic Enzymes Sales by Manufacturer 20
    • 3.1.1 Therapeutic Enzymes Sales by Manufacturer 20
    • 3.1.2 Therapeutic Enzymes Sales Market Share by Manufacturer 21
  • 3.2 Therapeutic Enzymes Revenue by Manufacturer 22
    • 3.2.1 Therapeutic Enzymes Revenue by Manufacturer (2018-2019) 23
    • 3.2.2 Therapeutic Enzymes Revenue Share by Manufacturer (2018-2019) 23
    • 3.2.3 Global Market Concentration Ratio (CR5) 24
  • 3.3 Therapeutic Enzymes Price by Manufacturer 25
  • 3.4 Therapeutic Enzymes Headquarters, Established Date and Product Type 25
    • 3.4.1 Therapeutic Enzymes Manufacturers Headquarters and Established Date 25
    • 3.4.2 Manufacturers Therapeutic Enzymes Product Type 26
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 27

4 Breakdown Data by Type 33

  • 4.1 Global Therapeutic Enzymes Sales by Type 33
  • 4.2 Global Therapeutic Enzymes Revenue by Type 34
  • 4.3 Therapeutic Enzymes Price by Type 36

5 Breakdown Data by Application 37

  • 5.1 Overview 37
  • 5.2 Global Therapeutic Enzymes Breakdown Data by Application 37

6 North America 40

  • 6.1 North America Therapeutic Enzymes by Country 41
    • 6.1.1 North America Therapeutic Enzymes Sales by Country 41
    • 6.1.2 North America Therapeutic Enzymes Revenue by Country 42
    • 6.1.3 United States 44
    • 6.1.4 Canada 45
    • 6.1.5 Mexico 46
  • 6.2 North America Therapeutic Enzymes by Type 47
  • 6.3 North America Therapeutic Enzymes by Application 48

7 Europe 50

  • 7.1 Europe Therapeutic Enzymes by Country 51
    • 7.1.1 Europe Therapeutic Enzymes Sales by Country 51
    • 7.1.2 Europe Therapeutic Enzymes Revenue by Country 52
    • 7.1.3 Germany 54
    • 7.1.4 France 55
    • 7.1.5 UK 56
    • 7.1.6 Italy 57
    • 7.1.7 Russia 58
  • 7.2 Europe Therapeutic Enzymes by Type 59
  • 7.3 Europe Therapeutic Enzymes by Application 60

8 Asia Pacific 61

  • 8.1 Asia Pacific Therapeutic Enzymes by Region 62
    • 8.1.1 Asia Pacific Therapeutic Enzymes Sales by Region 62
    • 8.1.2 Asia Pacific Therapeutic Enzymes Revenue by Region 63
    • 8.1.3 China 65
    • 8.1.4 Japan 66
    • 8.1.5 South Korea 67
    • 8.1.6 India 68
    • 8.1.7 Southeast Asia 69
  • 8.2 Asia Pacific Therapeutic Enzymes by Type 70
  • 8.3 Asia Pacific Therapeutic Enzymes by Application 71

9 South America 72

  • 9.1 South America Therapeutic Enzymes by Country 73
    • 9.1.1 South America Therapeutic Enzymes Sales by Country 73
    • 9.1.2 South America Therapeutic Enzymes Revenue by Country 74
    • 9.1.3 Brazil 76
  • 9.2 South America Therapeutic Enzymes by Type 77
  • 9.3 South America Therapeutic Enzymes by Application 78

10 The Middle East and Africa 80

  • 10.1 the Middle East and Africa Therapeutic Enzymes by Country 81
    • 10.1.1 the Middle East and Africa Therapeutic Enzymes Sales by Country 81
    • 10.1.2 the Middle East and Africa Therapeutic Enzymes Revenue by Country 82
    • 10.1.3 Egypt 83
    • 10.1.4 South Africa 85
  • 10.2 the Middle East and Africa Therapeutic Enzymes by Type 86
  • 10.3 the Middle East and Africa Therapeutic Enzymes by Application 87

11 Analysis of Therapeutic Enzymes Industry Key Manufacturers 89

  • 11.1 Sanofi 89
    • 11.1.1 Company Profile 89
    • 11.1.2 Product Information 90
    • 11.1.3 Sales, Price, Revenue and Gross Margin 91
  • 11.2 BioMarin 91
    • 11.2.1 Company Profile 91
    • 11.2.2 Product Information 93
    • 11.2.3 Sales, Price, Revenue and Gross Margin 93
  • 11.3 AbbVie 94
    • 11.3.1 Company Profile 94
    • 11.3.2 Product Information 96
    • 11.3.3 Sales, Price, Revenue and Gross Margin 96
  • 11.4 Shire 97
    • 11.4.1 Company Profile 97
    • 11.4.2 Product Information 98
    • 11.4.3 Sales, Price, Revenue and Gross Margin 99
  • 11.5 Alexion 99
    • 11.5.1 Company Profile 99
    • 11.5.2 Product Information 100
    • 11.5.3 Sales, Price, Revenue and Gross Margin 101
  • 11.6 Horizon Pharma 101
    • 11.6.1 Company Profile 101
    • 11.6.2 Product Information 102
    • 11.6.3 Sales, Price, Revenue and Gross Margin 103
  • 11.7 Allergan 103
    • 11.7.1 Company Profile 103
    • 11.7.2 Product Information 104
    • 11.7.3 Sales, Price, Revenue and Gross Margin 105
    • 11.8.8 Johnson & Johnson 105
    • 11.8.1 Company Profile 105
    • 11.8.2 Product Information 106
    • 11.8.3 Sales, Price, Revenue and Gross Margin 107
  • 11.9 Recordati Rare Diseases 107
    • 11.9.1 Company Profile 107
    • 11.9.2 Product Information 108
    • 11.9.3 Sales, Price, Revenue and Gross Margin 109
  • 11.10 Pfizer 109
    • 11.10.1 Company Profile 109
    • 11.10.2 Product Information 110
    • 11.10.3 Sales, Price, Revenue and Gross Margin 111
  • 11.11 Vivus 111
    • 11.11.1 Company Profile 111
    • 11.11.2 Product Information 112
    • 11.11.3 Sales, Price, Revenue and Gross Margin 113
  • 11.12 Digestive Care 113
    • 11.12.1 Company Profile 113
    • 11.12.2 Product Information 114
    • 11.12.3 Sales, Price, Revenue and Gross Margin 115
  • 11.13 Leadiant Biosciences 115
    • 11.13.1 Company Profile 115
    • 11.13.2 Product Information 116
    • 11.13.3 Sales, Price, Revenue and Gross Margin 117

12 Future Forecast 118

  • 12.1 Therapeutic Enzymes Market Forecast by Region 118
    • 12.1.1 Global Therapeutic Enzymes Sales Forecast by Region (2020-2025) 118
    • 12.1.2 Global Therapeutic Enzymes Revenue Forecast by Region (2020-2025) 119
  • 12.2 Therapeutic Enzymes Market Forecast by Type 120
    • 12.2.1 Global Therapeutic Enzymes Sales Forecast by Type (2020-2025) 120
    • 12.2.2 Global Therapeutic Enzymes Revenue Forecast by Type (2020-2025) 121
  • 12.3 Therapeutic Enzymes Market Forecast by Application 121
  • 12.4 North America Therapeutic Enzymes Forecast 122
  • 12.5 Europe Therapeutic Enzymes Forecast 123
  • 12.6 Asia Pacific Therapeutic Enzymes Forecast 124
  • 12.7 South America Therapeutic Enzymes Forecast 125
  • 12.8 Middle East and Africa Therapeutic Enzymes Forecast 126

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 128

  • 13.1 Market Opportunities and Drivers 128
  • 13.2 Market Challenges 129
  • 13.3 New Drug Development 129
    • 13.3.1 Avrobio Raises $60M for Fabry Disease Gene Therapy, Rest of Pipeline 129
    • 13.3.2 RVT-801 (RHAC) 131
    • 13.3.3 AzurRx BioPharma 132
  • 13.4 Porter?? Five Forces Analysis 132

14 Value Chain and Sales Channels Analysis 134

  • 14.1 Value Chain Analysis 134
  • 14.2 Therapeutic Enzymes Customers 135
  • 14.3 Sales Channels Analysis 137
    • 14.3.1 Sales Channels 137
    • 14.3.2 Distributors 138

15 Research Findings and Conclusion 141

16 Appendix 142

  • 16.1 Research Methodology 142
    • 16.1.1 Methodology/Research Approach 142
      • 16.1.1.1 Research Programs/Design 142
      • 16.1.1.2 Market Size Estimation 143
      • 16.1.1.3 Market Breakdown and Data Triangulation 144
    • 16.1.2 Data Source 146
      • 16.1.2.1 Secondary Sources 146
      • 16.1.2.2 Primary Sources 147
  • 16.2 Author Details 148
  • 16.3 Disclaimer 148
Back to Top